Joshua F. Patterson serves as Executive at AKCEA THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Joshua F. Patterson has executed 9 insider transactions totaling $13.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 31, 2024 involved receiving (via award) 480,319 shares valued at $0.
Joshua F. Patterson currently holds 855,461 shares of AKCEA THERAPEUTICS, INC. (AKCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joshua F. Patterson has been a net seller of AKCA stock. They have purchased $0 and sold $13.0K worth of shares.
Joshua F. Patterson's most recent insider trade was on Jan 31, 2024, when they sold 480,319 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 28, 2022 | GMDA | $0 | Award | 51,000 | $N/A | Discretionary |
| Oct 12, 2020 | AKCA | $481.6K | Tender | 26,532 | $18.15 | Discretionary |
| Sep 22, 2020 | AKCA | $5.8K | Sale | 319 | $18.12 | Discretionary |
| Jul 17, 2020 | AKCA | $3.3K | Sale | 263 | $12.50 | Discretionary |
| Apr 15, 2020 | AKCA | $0 | Award | 12,500 | $N/A | Discretionary |
| Mar 23, 2020 | AKCA | $3.9K | Sale | 335 | $11.76 | Discretionary |
| Mar 19, 2020 | AKCA | $0 | Award | 3,780 | $N/A | Discretionary |